Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial
Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page
- Check5 days agoChange DetectedRecruitment is now indicated as closed ('No longer looking for participants'), reflecting that the study is not enrolling any more participants. The update also adjusts the Intervention/Treatment label and adds a page revision tag (Revision: v3.6.0).SummaryDifference0.4%

- Check12 days agoChange DetectedFooter revision updated from v3.5.4 to v3.5.5. This indicates a minor maintenance update to the study record page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now lists a newer site revision label 'Revision: v3.5.4', replacing 'Revision: v3.5.3'. This reflects a deployment update to the ClinicalTrials.gov interface rather than a change to the study information.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.5.3 replaces the previous v3.5.2 on the page. This reflects a minor platform update to the study record interface.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded “Type 2 diabetes” related topics, including a MedlinePlus Genetics section.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.